AU7046201A - Medicament for the treatment of immune reactions in the eye - Google Patents

Medicament for the treatment of immune reactions in the eye

Info

Publication number
AU7046201A
AU7046201A AU70462/01A AU7046201A AU7046201A AU 7046201 A AU7046201 A AU 7046201A AU 70462/01 A AU70462/01 A AU 70462/01A AU 7046201 A AU7046201 A AU 7046201A AU 7046201 A AU7046201 A AU 7046201A
Authority
AU
Australia
Prior art keywords
medicament
eye
treatment
immune reactions
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70462/01A
Inventor
Friedrich Hoffmann
Sven Andreas Konig Merediz
Burghardt Wittig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLOGEN FORSCHUNGS- ENTWICKLUNGS- und VERTRIEBS GmbH
Original Assignee
MOLOGEN FORSCHUNGS ENTWICKLUNG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOLOGEN FORSCHUNGS ENTWICKLUNG filed Critical MOLOGEN FORSCHUNGS ENTWICKLUNG
Publication of AU7046201A publication Critical patent/AU7046201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU70462/01A 2000-05-27 2001-05-27 Medicament for the treatment of immune reactions in the eye Abandoned AU7046201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025920 2000-05-27
DE10025920A DE10025920A1 (en) 2000-05-27 2000-05-27 Methods and agents for treating immune reactions in the eye
PCT/DE2001/002081 WO2001091799A2 (en) 2000-05-27 2001-05-27 Medicament for the treatment of immune reactions in the eye

Publications (1)

Publication Number Publication Date
AU7046201A true AU7046201A (en) 2001-12-11

Family

ID=7643528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70462/01A Abandoned AU7046201A (en) 2000-05-27 2001-05-27 Medicament for the treatment of immune reactions in the eye

Country Status (3)

Country Link
AU (1) AU7046201A (en)
DE (2) DE10025920A1 (en)
WO (1) WO2001091799A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
CA2192660A1 (en) * 1994-06-15 1995-12-21 Mauro S. Sandrin Methods for reducing hyperacute rejection of xenografts
DE19648625A1 (en) * 1996-11-13 1998-05-14 Soft Gene Gmbh Microprojectile for the introduction of substances into cells by ballistic transfer

Also Published As

Publication number Publication date
WO2001091799A2 (en) 2001-12-06
DE10192165D2 (en) 2002-08-29
WO2001091799A3 (en) 2002-08-01
DE10025920A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2001227837A1 (en) Novel treatment for eye disease
AUPQ514600A0 (en) Brain injury treatment
AU5259100A (en) Medicament
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
MXPA03005731A (en) Absorbent article having releasable medicinal treatments.
AU2002253039A1 (en) Tramadol-based medicament
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU5215300A (en) Dental treatment area
AU2002347671A1 (en) Ophthalmic device for administering fluid eye medication to the human eye
AU2002227935A1 (en) Optical stimulation of the human eye
AU2001260834A1 (en) The treatment of herpes
AU2001243515A1 (en) Combination drug therapy
AU4770800A (en) Body treatment product
AU2002319286A1 (en) Skin treatment
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU7046201A (en) Medicament for the treatment of immune reactions in the eye
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
AU6896300A (en) Vaccines for the treatment of autoimmune disease
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase